4 results
To evaluate the tumor targeting performance of the human radiolabeled antibody 124I-F16SIP.To investigate pharmacokinetics/-dynamics of 124I-F16SIP, and to assess its uptake in tumor and normal tissues as obtained from the surgical specimen.
Establish the technical feasibility and safety of implantation of the investigational device, adjustment of the investigational device post-implantation and the ability of the investigational device to reduce mitral valve regurgitation.
To establish the accuracy of the Medtrum TouchCare Nano 14 CGM system compared to thecurrent gold standards i.e. established central laboratory technique (the StatStrip Xpress®monitoring system (Nova Biomedical, Waltham, WA), the accuracy of a…
To establish the performance of the TouchCare Nano 14 CGM system among persons with DM.